Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease.
Risner ME; Saunders AM; Altman JF; Ormandy GC; Craft S; Foley IM; Zvartau-Hind ME; Hosford DA; Roses AD; The Pharmacogenomics Journal, 2006, vol. 6, issue 4, p 246, ISSN 1470269x. ISBN 1470269x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef